Cln5-deficiency in mice leads to microglial activation, defective myelination and changes in lipid metabolism
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
CLN5 disease, late infantile variant phenotype neuronal ceroid lipofuscinosis, is a severe neurodegenerative disease caused by mutations in the CLN5 gene, which encodes a lysosomal protein of unknown function. Cln5-deficiency in mice leads to loss of thalamocortical neurons, and glial activation, but the underlying mechanisms are poorly understood. We have now studied the gene expression of Cln5 in the mouse brain and show that it increases gradually with age and differs between neurons and glia, with the highest expression in microglia. In Cln5(-/-) mice, we documented early and significant microglial activation that was already evident at 3 months of age. Loss of Cln5 also leads to defective myelination in vitro and in the developing mouse brain. This was accompanied by early alterations in serum lipid profiles, dysfunctional cellular metabolism and lipid transport in Cln5(-/-) mice. Taken together, these data provide significant new information about events associated with Cln5-deficiency, revealing altered myelination and disturbances in lipid metabolism, together with an early neuroimmune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
A Method for the Combined Staining of Cells and Fibers in the Nervous System
Klüver, H., & Barrera, E. (1953) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-195312040-00008 · Cited by 1,724
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Microglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476
Dietschy, J. M., & Turley, S. D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400004-jlr200 · Cited by 1,095
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
High cholesterol level is essential for myelin membrane growth
Saher, G., Brügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R.-I., Wehr, M. C., Wieland, F., Ishibashi, S., & Nave, K.-A. (2005) · Nature Neuroscience · doi:10.1038/nn1426 · Cited by 799
Myelin basic protein: a multifunctional protein
Boggs, J. M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6094-7 · Cited by 687
TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains?
Winter, E., & Ponting, C. P. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02154-0 · Cited by 181
Cited by
Feng, T., Lacrampe, A., & Hu, F. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02246-3 · Cited by 110
A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis
Basak, I., Wicky, H. E., McDonald, K. O., Xu, J. B., Palmer, J. E., Best, H. L., Lefrancois, S., Lee, S. Y., Schoderboeck, L., & Hughes, S. M. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03813-x · Cited by 32
Qureshi, Y. H., Baez, P., & Reitz, C. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00262-20 · Cited by 25
Deficiency of the Lysosomal Protein CLN5 Alters Lysosomal Function and Movement
Basak, I., Hansen, R. A., Ward, M. E., & Hughes, S. M. (2021) · Biomolecules · doi:10.3390/biom11101412 · Cited by 23
“Loss of CLN5 is further associated with different neuronal and non-neuronal pathologies, including accumulation of autofluorescent storage materials [4,9–11], impaired retromer trafficking and endosomal sorting [12–14], disturbed lipid metabolism [15], metal imbalance [16], and mitochondrial dysfunction [17].”
Background
Metadata
- Authors
- Schmiedt, M.-L., Blom, T., Blom, T., Kopra, O., Wong, A., von Schantz-Fant, C., Ikonen, E., Kuronen, M., Jauhiainen, M., Cooper, J. D., & Jalanko, A.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 46
- Issue
- 1
- Pages
- 19-29
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2002982587
- Cited by
- 47
- References
- 14
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cln5-deficiency in mice leads to microglial activation, defective myelination and changes in lipid metabolism. https://app.cochat.ai/papers/10.1016/j.nbd.2011.12.009
- The paper
- Schmiedt, M.-L., Blom, T., Blom, T., Kopra, O., Wong, A., von Schantz-Fant, C., Ikonen, E., Kuronen, M., Jauhiainen, M., Cooper, J. D., & Jalanko, A. (2012). Cln5-deficiency in mice leads to microglial activation, defective myelination and changes in lipid metabolism. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2011.12.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.